Bio-Techne Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Bio-Techne stock has a consensus rating of "Hold" and an average price target of $70.5. The average 1-year stock price forecast is 2.83% lower than the current stock price, while the lowest is $50 (-31.08%) and the highest is $73 (+0.62%).

Price Target: $70.5 (-2.83%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$50	$70.5	$73	$73
Change	-31.08%	-2.83%	+0.62%	+0.62%

* Price targets were last updated on Aug 13, 2026.

Analyst Ratings

The average analyst rating for Bio-Techne stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	9	3	2	1	1	1
Buy	2	1	0	0	0	0
Hold	4	11	12	13	12	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	14	14	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dan Leonard RBC Capital	RBC Capital	Hold Maintains $73	Hold	Maintains	$73	+0.62%	Aug 13, 2026
Matt Larew William Blair	William Blair	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 12, 2026
Kyle Boucher TD Cowen	TD Cowen	Hold Downgrades $65 → $73	Hold	Downgrades	$65 → $73	+0.62%	Jul 1, 2026
Robert Wasserman StoneX	StoneX	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 30, 2026
Patrick B Donnelly Citi	Citi	Hold Downgrades $70 → $73	Hold	Downgrades	$70 → $73	+0.62%	Jun 29, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.27B

from 1.22B

4.35%

from 1.22B

Revenue Next Year

1.40B

from 1.27B

10.04%

from 1.27B

EPS This Year

2.04

from 1.93

5.54%

from 1.93

EPS Next Year

2.31

from 2.04

13.53%

from 2.04

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	1.11B	1.14B	1.16B	1.22B	1.22B	1.27B
Revenue Growth	18.75%	2.81%	1.97%	5.23%	-0.38%	4.35%
Gross Profit	758.09M	770.22M	773.80M	811.12M	804.88M	860.27M
Gross Margin	68.57%	67.76%	66.76%	66.50%	66.24%	67.85%
Operating Income	279.06M	281.11M	248.60M	223.41M	274.55M	363.98M
Net Income	272.05M	285.26M	168.11M	73.40M	181.86M	202.36M
EPS	-	-	-	-	1.93	2.04
EPS Growth	-	-	-	-	0.52%	5.54%
Forward PE	39.55	36.57	36.72	25.74	35.26	35.62
Dividend / Share	0.32	0.32	0.32	0.32	0.32	0.32
Dividend Growth	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	263.22M	288.60M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	1.3B
Avg	1.3B
Low	1.2B

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	6.2%
Avg	4.4%
Low	2.9%

EPS Forecast

Chart

EPS	2027	2028	2029
High	2.15
Avg	2.04
Low	1.82

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	11.4%
Avg	5.5%
Low	-5.7%